A pan-cancer-bioinformatic-based literature review of TRPM7 in cancers
TRPM7, a divalent cation-selective channel with kinase domains, has been widely reported
to potentially affect cancers. In this study, we conducted multiple bioinformatic analyses …
to potentially affect cancers. In this study, we conducted multiple bioinformatic analyses …
[HTML][HTML] Cystathionine gamma-lyase (CTH) inhibition attenuates glioblastoma formation
Purpose Glioblastoma (GBM) is the most common type of adult brain tumor with extremely
poor survival. Cystathionine-gamma lyase (CTH) is one of the main Hydrogen Sulfide (H 2 …
poor survival. Cystathionine-gamma lyase (CTH) is one of the main Hydrogen Sulfide (H 2 …
CTR-DB, an omnibus for patient-derived gene expression signatures correlated with cancer drug response
Z Liu, J Liu, X Liu, X Wang, Q **e, X Zhang… - Nucleic Acids …, 2022 - academic.oup.com
To date, only some cancer patients can benefit from chemotherapy and targeted therapy.
Drug resistance continues to be a major and challenging problem facing current cancer …
Drug resistance continues to be a major and challenging problem facing current cancer …
[HTML][HTML] A bioinformatic study of IGFBPs in glioma regarding their diagnostic, prognostic, and therapeutic prediction value
H Liu, T Tang - American Journal of Translational Research, 2023 - ncbi.nlm.nih.gov
Background: It is essential to develop better biomarkers for diagnosis, prediction, and
treating glioma patients to ensure successful clinical outcomes. The clinical application of …
treating glioma patients to ensure successful clinical outcomes. The clinical application of …
Interferon‐γ inducible protein 30 promotes the epithelial–mesenchymal transition‐like phenotype and chemoresistance by activating EGFR/AKT/GSK3β/β‐catenin …
Y Chen, H Xu, P Yu, Q Wang, S Li, F Ji… - CNS Neuroscience & …, 2023 - Wiley Online Library
Aims Previous studies have indicated that IFI30 plays a protective role in human cancers.
However, its potential roles in regulating glioma development are not fully understood …
However, its potential roles in regulating glioma development are not fully understood …
Aberrant mitochondrial homeostasis at the crossroad of musculoskeletal ageing and non-small cell lung cancer
Cancer cachexia is accompanied by muscle atrophy, sharing multiple common catabolic
pathways with sarcopenia, including mitochondrial dysfunction. This study investigated gene …
pathways with sarcopenia, including mitochondrial dysfunction. This study investigated gene …
Bioinformatic and clinical experimental assay uncovers resistance and susceptibility mechanisms of human glioblastomas to temozolomide and identifies new …
A Modestov, M Zolotovskaia… - … in medical oncology, 2024 - journals.sagepub.com
Background: Glioblastoma (GBM) is the most aggressive and lethal central nervous system
(CNS) tumor. The treatment strategy is mainly surgery and/or radiation therapy, both …
(CNS) tumor. The treatment strategy is mainly surgery and/or radiation therapy, both …
Chaperone-mediated autophagy controls proteomic and transcriptomic pathways to maintain glioma stem cell activity
J Auzmendi-Iriarte, M Otaegi-Ugartemendia… - Cancer research, 2022 - AACR
Chaperone-mediated autophagy (CMA) is a homeostatic process essential for the lysosomal
degradation of a selected subset of the proteome. CMA activity directly depends on the …
degradation of a selected subset of the proteome. CMA activity directly depends on the …
Identification of MDM2 as a prognostic and immunotherapeutic biomarker in a comprehensive pan-cancer analysis: A promising target for breast cancer, bladder …
J Zheng, F Miao, Z Wang, Y Ma, Z Lin, Y Chen, X Kong… - Life Sciences, 2023 - Elsevier
Background The murine double minute 2 (MDM2) gene is a crucial factor in the
development and progression of various cancer types. Multiple rigorous scientific studies …
development and progression of various cancer types. Multiple rigorous scientific studies …
A Proteomic Investigation to Discover Candidate Proteins Involved in Novel Mechanisms of 5-Fluorouracil Resistance in Colorectal Cancer
One of the main obstacles to therapeutic success in colorectal cancer (CRC) is the
development of acquired resistance to treatment with drugs such as 5-fluorouracil (5-FU) …
development of acquired resistance to treatment with drugs such as 5-fluorouracil (5-FU) …